...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Annual Financial Reporting

 No worries koo , just a gut feeling & some reoccurring frustration on my part.
If I've mis read your comments , my apologies, sorry. It will be what it will be.

glta 

Share
New Message
Please login to post a reply